Schröter, Nils
Arnold, Philipp G.
Hosp, Jonas A
Reisert, Marco
Rijntjes, Michel
Kellner, Elias
Jost, Wolfgang H.
Weiller, Cornelius
Urbach, Horst
Rau, Alexander http://orcid.org/0000-0001-5881-6043
Funding for this research was provided by:
Universitätsklinikum Freiburg
Article History
Received: 19 October 2023
Accepted: 24 December 2023
First Online: 30 January 2024
Declarations
:
: N. Schröter received grants from Berta-Ottenstein-Programme for Clinician Scientists, Faculty of Medicine, University of Freiburg, and honoraria from AbbVie (presentations). M. Reisert received honoraria from AbbVie (presentations). E. Kellner is a shareholder of and receives fees from VEObrain GmbH, Freiburg, Germany. H. Urbach is co-editor of Clinical Neuroradiology, member of the Advisory Board of Biogen and received honoraria for lectures from Biogen, Eisai, and mbits. A. Rau received grants from Berta-Ottenstein-Programme for Clinician Scientists, Faculty of Medicine, University of Freiburg. All declared interests are independent of the submitted work. P.G. Arnold, J.A. Hosp, M. Rijntjes, W.H. Jost and C. Weiller declare that they have no competing interests.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.